Virological investigation of elephant endotheliotropic herpesvirus 1B infection in an Australian captive herd of Asian elephants (Elephas maximus)

This study investigates a fatal EEHV1B infection in a captive Asian elephant by analyzing viral dynamics, tissue viral loads, and comparative genomics, revealing high viral loads, optimal sample preservation methods, and evidence of recombination between EEHV subspecies that may impact disease pathogenesis and diagnostics.

The Gist

Imagine a herd of Asian elephants living in an Australian zoo. They are like a close-knit family, but they are under constant, invisible threat from a microscopic enemy: a virus called EEHV (Elephant Endotheliotropic Herpesvirus).

Think of EEHV as a "sleeping dragon" that lives inside many elephants. Usually, it's harmless, just like a cold sore virus in humans that stays quiet until the immune system is stressed. But sometimes, this dragon wakes up, attacks the elephant's blood vessels, and causes a massive internal bleed. This is called EEHV-HD (Hemorrhagic Disease), and it is often fatal, especially for young elephants.

Here is the story of what happened in this specific zoo, explained simply:

1. The Unexpected Victim

Usually, this dragon only attacks young elephants (between 2 and 8 years old) because their immune systems are still learning. But in this story, the victim was a 9-year-old male elephant. He was older than the usual "danger zone," which surprised the vets. Despite the vets trying everything to save him, he passed away very quickly—within three days of showing the first signs of being sick.

2. The "Fingerprints" of the Virus

The scientists wanted to know exactly which version of the virus killed him. There are different "flavors" of EEHV, like different models of the same car. The most common killer is EEHV1A, but this elephant was infected with the rarer EEHV1B.

To find out, they took samples from the dead elephant's heart and intestines. They treated these samples like crime scene evidence, using special liquids to preserve the DNA. They discovered that Viral Transport Medium (a specific liquid used to keep viruses alive) was the best "preservative," keeping the most viral DNA intact for study.

3. The Herd's "Sneezing" Pattern

Viruses spread like colds. The scientists looked at "trunk washes" (basically, rinsing out the elephant's nose with water) from the whole herd to see who was carrying the virus.

• Before the tragedy: Only a few elephants were "shedding" (releasing) the virus.
• After the tragedy: Suddenly, almost everyone in the herd started shedding the virus.

It's as if one person in a house got a bad flu, and suddenly, everyone else in the house started sneezing too. This suggests that when an elephant gets sick, the virus spreads rapidly through the herd, even if the others don't get sick themselves.

4. The Genetic "Mosaic" (The Big Discovery)

This is the most exciting part. The scientists sequenced the entire genome of the virus (its complete instruction manual).

Imagine the virus's DNA as a long book. Usually, EEHV1A and EEHV1B are two different editions of this book. But when they read this specific virus's book, they found something strange: It was a patchwork quilt.

• Most of the book looked like the EEHV1B edition.
• But several chapters (specifically the parts that help the virus sneak into cells and hide from the immune system) looked exactly like the EEHV1A edition.

The Analogy: Think of it like a car. The engine and wheels are from a Ford (EEHV1B), but the steering wheel and dashboard are from a Toyota (EEHV1A). The virus swapped parts with its cousin.

Why Does This Matter?

This "genetic swapping" (recombination) is a big deal for three reasons:

1. It's a Shape-shifter: By swapping parts, the virus might be learning new tricks to hide from the immune system or to infect elephants that are usually safe.
2. It Confuses the Tests: The tests vets use to detect the virus look for specific "fingerprints." If the virus swaps those fingerprints, the test might miss it.
3. It Challenges Vaccines: If we make a vaccine for EEHV1A, but the virus swaps in EEHV1B parts, the vaccine might not work.

The Takeaway

This paper is a warning and a guide. It tells us that:

• Age isn't everything: Even older elephants can get sick if the virus changes.
• The herd is connected: When one gets sick, the whole herd becomes a carrier.
• The virus is evolving: It's mixing and matching its genetic code, which makes it harder to catch and cure.

The scientists are now calling for more cooperation between zoos and researchers to keep watching this "dragon," sequence its DNA, and figure out how to stop it before it takes more lives. They are essentially trying to read the virus's instruction manual faster than the virus can rewrite it.

Technical Summary

1. Problem Statement

Elephant Endotheliotropic Herpesvirus (EEHV) is a leading cause of mortality in captive Asian elephants, particularly affecting young individuals (2–8 years old) with a high fatality rate (68–85%) due to hemorrhagic disease (EEHV-HD). While EEHV1A is the most common cause of fatal disease, EEHV1B is less frequently documented but still poses a significant threat.

• Knowledge Gaps: There is a scarcity of whole-genome sequences for EEHV1B (only one previously published from 2006), limited understanding of viral dynamics within herds, unclear tissue tropism differences between EEHV1A and 1B, and insufficient data on the impact of sample storage media on viral DNA recovery.
• Specific Case: This study investigates a fatal EEHV-HD case in a nine-year-old male Asian elephant in Australia. This age is atypical, as most fatal cases occur in younger elephants, raising questions about risk factors and the reliability of age-based surveillance.

2. Methodology

The study employed a multi-faceted approach combining clinical surveillance, molecular diagnostics, and advanced genomics:

• Herd Surveillance: Routine trunk wash samples and whole blood samples were collected from a herd of 10 elephants (5 females, 1 adult male, 1 sub-adult male, 3 calves) over a 15-month period (3 months prior to and 12 months post-mortem of the fatal case).
• Molecular Detection (qPCR):
  • Samples were tested for EEHV1, 4, and 5, as well as host reference gene TNF-α.
  • Subtyping was performed to distinguish EEHV1A from EEHV1B.
  • Viral loads were quantified using standard curves to determine viral genome equivalents (VGE) per mL of blood or per cell in tissues.
• Post-Mortem Analysis:
  • Tissue samples (heart, liver, intestine, tongue, etc.) were collected 48 hours post-mortem.
  • Storage Media Comparison: Tissues were stored in four conditions: DNA/RNA Shield, RNALater, Viral Transport Medium (VTM), and plain tubes (frozen at -80°C without media) to assess DNA recovery efficiency.
• Genomic Sequencing:
  • Metagenomic Next-Generation Sequencing (mNGS) was performed on DNA extracted from heart and intestinal tissues using Illumina NovaSeq.
  • Assembly: A hybrid assembly approach was used, combining de novo assembly (MEGAHIT) with iterative mapping to the reference EEHV1B genome (Emelia, KC462164).
  • Comparative Genomics: The assembled genome (EEHV1B_AUP_01_2023) was aligned with EEHV1A and EEHV1B references. Phylogenetic analysis (maximum likelihood) and recombination analysis (SplitsTree, SimPlot++) were conducted to identify recombination events and evolutionary relationships.

3. Key Results

Clinical and Virological Dynamics

• Fatal Case: The 9-year-old elephant succumbed to EEHV-HD within three days of symptom onset despite treatment.
• Viral Load: A marked viraemia was detected at the onset of clinical signs, peaking at 5.47 x 10⁶ VGE/mL on day 2.
• Herd Shedding: Following the fatal event, EEHV1B shedding in trunk washes increased significantly across the herd (44.4% positivity in the 3 months post-event vs. 20.7% pre-event). Notably, one elephant showed high shedding levels 7 weeks prior to the fatal case, suggesting a prolonged incubation or delayed exposure.
• Age Factor: The case challenges the assumption that EEHV-HD is exclusively a disease of young elephants, highlighting the need for serological monitoring in older animals.

Tissue Tropism and Storage Media

• Tissue Tropism: The heart contained the highest viral load, followed by the liver, gastrointestinal tract, and tongue. This contrasts with some EEHV1A cases where the liver is the primary site of high load, suggesting potential differences in tissue tropism between subspecies.
• Storage Media: Tissues stored in Viral Transport Medium (VTM) yielded the highest recovery of both viral and host DNA. However, tissues stored frozen without media were still suitable for molecular detection, offering a practical option for resource-limited settings.

Genomic Findings

• Genome Assembly: A complete genome of 178.3 kb was assembled (GenBank: PX651398). It showed 96.0% nucleotide identity to the reference EEHV1B (Emelia) and ~90% identity to EEHV1A.
• Recombination: The study provided strong evidence of recombination between EEHV1A and EEHV1B subspecies.
  • Specific regions (L1, L2, and the R2 region) showed high similarity to EEHV1A sequences despite the genome being classified as EEHV1B.
  • The R2 region (9.8 kb) shared >99% identity with an EEHV1A sequence (NAP20) but only 68% with the EEHV1B reference.
  • Genes involved in immune evasion (vGPCRs, vOX2-like proteins) were frequently located in these recombinant regions.
• Selection Pressure: The genome showed strong purifying selection (dN/dS < 0.5) across most genes, with diversifying selection observed in only five genes (E18A, E18B, E31, E37, E38), likely driven by host immune pressure.

4. Key Contributions

1. Second EEHV1B Whole Genome: This is only the second complete EEHV1B genome published, providing a crucial reference for comparative genomics.
2. Evidence of Recombination: The study definitively demonstrates that recombination between EEHV1A and 1B occurs in nature, particularly in hypervariable regions encoding immune-modulatory proteins.
3. Tissue Tropism Data: It provides the first comparative data on EEHV1B tissue loads, identifying the heart as the primary site of viral replication in this fatal case.
4. Methodological Validation: It validates the use of VTM for optimal DNA recovery while confirming that frozen tissue without media is sufficient for qPCR, aiding field diagnostics.
5. Epidemiological Insight: It documents the first known EEHV1B-HD case in Australia and highlights the risk of fatal disease in elephants older than the typical high-risk age group.

5. Significance and Implications

• Diagnostics and Vaccines: The discovery of recombination in regions encoding key glycoproteins (gB, gH, gL) and thymidine kinase suggests that current molecular assays, vaccines, and antiviral therapies targeting these specific sequences may become ineffective if recombination events alter these targets.
• Conservation Management: The findings underscore the need for routine serological monitoring (not just age-based) and increased surveillance frequency (weekly trunk washes) to detect shedding events earlier.
• Evolutionary Understanding: The study supports the hypothesis that recombination, rather than just mutation, is a primary driver of EEHV evolution and immune evasion, similar to other herpesviruses like HCMV.
• Future Research: The authors call for continued whole-genome sequencing of EEHV cases to monitor the frequency of recombination and its impact on pathogenicity and control measures.